Ubiquinol (reduced Coenzyme Q10) in patients with severe sepsis or septic shock: a randomized, double-blind, placebo-controlled, pilot trial

INTRODUCTION: We previously found decreased levels of Coenzyme Q10 (CoQ10) in patients with septic shock. The objective of the current study was to assess whether the provision of exogenous ubiquinol (the reduced form of CoQ10) could increase plasma CoQ10 levels and improve mitochondrial function. M...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Crit Care
Glavni autori: Donnino, Michael W., Mortensen, Sharri J., Andersen, Lars W., Chase, Maureen, Berg, Katherine M., Balkema, Julia, Radhakrishnan, Jeejabai, Gazmuri, Raúl J., Liu, Xiaowen, Cocchi, Michael N.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2015
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4520066/
https://ncbi.nlm.nih.gov/pubmed/26130237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-015-0989-3
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items